The aim of this study was to enhance the comprehension of radiomic features linked with KRAS and EGFR mutations in lung adenocarcinoma and evaluate the effectiveness of these features in accurately classifying mutations. This evidence concerns the gene EGFR and lung adenocarcinoma.